Back to Search
Start Over
Constitutive Cyclin O deficiency results in penetrant hydrocephalus, impaired growth and infertility.
- Source :
-
Oncotarget [Oncotarget] 2017 Oct 12; Vol. 8 (59), pp. 99261-99273. Date of Electronic Publication: 2017 Oct 12 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- Cyclin O (encoded by CCNO ) is a member of the cyclin family with regulatory functions in ciliogenesis and apoptosis. Homozygous CCNO mutations have been identified in human patients with Reduced Generation of Multiple Motile Cilia (RGMC) and conditional inactivation of Ccno in the mouse recapitulates some of the pathologies associated with the human disease. These include defects in the development of motile cilia and hydrocephalus. To further investigate the functions of Ccno in vivo , we have generated a new mouse model characterized by the constitutive loss of Ccno in all tissues and followed a cohort during ageing. Ccno <superscript> -/- </superscript> mice were growth impaired and developed hydrocephalus with high penetrance. In addition, some Ccno <superscript> +/- </superscript> mice also developed hydrocephalus and affected Ccno <superscript> -/- </superscript> and Ccno <superscript> +/- </superscript> mice exhibited additional CNS defects including cortical thinning and hippocampal abnormalities. In addition to the CNS defects, both male and female Ccno <superscript> -/- </superscript> mice were infertile and female mice exhibited few motile cilia in the oviduct. Our results further establish CCNO as an important gene for normal development and suggest that heterozygous CCNO mutations could underlie hydrocephalus or diminished fertility in some human patients.<br />Competing Interests: CONFLICTS OF INTEREST The authors declare that they have no conflict of interest.
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 8
- Issue :
- 59
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Academic Journal
- Accession number :
- 29245899
- Full Text :
- https://doi.org/10.18632/oncotarget.21818